— Know what they know.
Not Investment Advice

SYRS OTC

Syros Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +300.0% YTD: +100.0% 1Y: +300.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±1453.3%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 44 · $10733 mcap · 27M float · 0.049% daily turnover · Short 27% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2024-10-23 Piper Sandler Edward Tenthoff $13 $5 -8 +102.4% $2.47
2024-06-26 Piper Sandler Edward Tenthoff Initiated $13 — +128.1% $5.70
2024-06-26 H.C. Wainwright Andrew Fein Initiated $15 — +163.2% $5.70
2022-08-09 Oppenheimer Mark Breidenbach Initiated $3 — -67.6% $9.27

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
19
Earnings Quality
79
Growth
12
Value
23
Momentum
20
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-15.01
Distress Zone
Piotroski F-Score
0/9
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
0.81
Bankruptcy prob: 69.2%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 1.02x
Accruals: 1.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SYRS scores -15.01, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SYRS scores 0/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SYRS's implied 69.2% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SYRS receives an estimated rating of B- (score: 20.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.85x
P/OCF
—
EV/EBITDA
-0.95x
EV/Revenue
224.15x
EV/EBIT
-0.94x
EV/FCF
-0.86x
Earnings Yield
-115.66%
FCF Yield
-118.31%
Shareholder Yield
0.14%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SYRS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.058
EBT / EBIT
×
EBIT Margin
-239.598
EBIT / Rev
×
Asset Turnover
0.003
Rev / Assets
×
Equity Multiplier
9.245
Assets / Equity
=
ROE
-777.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SYRS's ROE of -777.0% is driven by financial leverage (equity multiplier: 9.25x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
695.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Nancy A. Simonian,
M.D. Former President & Chief Executive Officer
$635,385 $477,174 $1,436,782
Conley Chee &
resident & Chief Executive Officer
$479,092 $369,460 $1,041,697
Eric R. Olson,
Ph.D. Former Chief Scientific Officer
$409,791 $140,700 $935,768
David A. Roth,
M.D Chief Medical Officer
$516,154 $160,800 $876,534
Jason Haas Financial
ancial Officer
$485,185 $160,800 $833,019

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,436,782
Avg Employee Cost (SGA/emp): $415,912
Employees: 68

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
68
-41.9% YoY
Revenue / Employee
$146,118
Rev: $9,936,000
Profit / Employee
$-2,420,206
NI: $-164,574,000
SGA / Employee
$415,912
Avg labor cost proxy
R&D / Employee
$1,590,485
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
ROE -95.6% -1.1% -84.8% -1.0% -99.0% -71.6% -89.8% -1.2% -98.5% -90.3% -1.3% -88.2% -49.1% -51.4% -85.7% -77.1% -2.2% -2.4% -3.9% -7.8% -7.77%
ROA -58.8% -61.0% -49.4% -53.1% -46.3% -38.4% -45.3% -54.4% -43.7% -46.5% -60.4% -42.1% -24.5% -24.4% -29.1% -29.5% -75.5% -85.0% -91.5% -84.0% -84.04%
ROIC -4.5% -108.4% -74.1% 138.4% 3.8% 10.8% -5.5% -3.1% -3.9% -4.3% -7.8% 1.9% 9.8% -18.1% 14.2% 9.7% 1.7% 3.2% 3.8% 9.6% 9.61%
ROCE -61.5% -55.1% -59.8% -69.5% -44.5% -33.5% -40.2% -50.0% -54.6% -75.2% -1.2% -44.5% -42.4% -48.9% -59.2% -83.8% -1.2% -1.4% -1.5% -1.6% -1.63%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 86.3% 88.4% 81.4% 1.1% 76.2% 77.0% 83.6% 27.7% — — — —
Operating Margin -39.7% -7.3% -5.3% -5.0% -5.1% -4.3% -5.1% -4.7% -3.3% -4.9% -5.4% -10.1% 6.6% -11.2% -12.0% -9.2% -70.0% — — — —
Net Margin -38.8% -7.2% -5.4% -5.1% -5.3% -2.9% -4.4% -4.6% -3.1% -4.3% -5.6% -5.4% -5.0% -5.1% -12.8% -10.7% -166.8% — — — —
EBITDA Margin -37.9% -6.9% -5.0% -4.8% -5.0% -2.6% -4.0% -4.3% -2.8% -4.3% -5.2% -7.3% 52.6% -7.4% -12.1% -10.2% -162.6% — — — —
FCF Margin -36.8% -13.7% -7.2% -5.0% -4.0% -4.6% -4.9% -5.0% -4.3% -4.5% -4.3% -4.9% -12.2% -17.2% -30.3% -30.2% -11.1% -14.9% -26.8% -259.2% -259.22%
OCF Margin -30.4% -10.2% -5.1% -3.8% -3.8% -4.5% -4.8% -5.0% -4.2% -4.5% -4.3% -4.9% -12.1% -17.0% -30.0% -29.9% -11.0% -14.9% -26.8% -259.1% -259.12%
ROA 3Y Avg snapshot only -64.88%
ROIC Economic snapshot only -1.79%
Cash ROA snapshot only -1.18%
NOPAT Margin snapshot only -228.25%
Pretax Margin snapshot only -253.41%
R&D / Revenue snapshot only 228.04%
SGA / Revenue snapshot only 60.29%
SBC / Revenue snapshot only 18.78%
Valuation
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
P/E Ratio -4.02 -3.42 -6.59 -5.50 -7.92 -5.67 -3.97 -3.03 -2.37 -0.78 -0.57 -0.58 -1.90 -1.71 -1.97 -1.73 -1.48 -1.44 -1.54 -0.86 -0.000
P/S Ratio 153.14 66.67 73.44 40.87 44.12 26.17 17.55 13.15 8.73 3.11 2.43 2.59 9.80 9.71 20.88 27.09 23.16 29.87 48.85 219.10 0.001
P/B Ratio 3.83 3.40 7.81 8.81 7.35 3.06 2.64 2.65 2.41 1.20 1.98 0.47 0.78 0.70 1.20 3.05 13.81 13.85 -31.90 -7.60 0.001
P/FCF -4.16 -4.87 -10.25 -8.17 -10.97 -5.64 -3.61 -2.62 -2.04 -0.69 -0.57 -0.52 -0.80 -0.57 -0.69 -0.90 -2.09 -2.01 -1.82 -0.85 -0.845
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -3.17 -2.46 -5.95 -5.12 -7.05 -4.03 -2.83 -2.34 -1.76 -0.35 -0.41 1.12 0.45 0.30 -0.08 -0.65 -0.97 -1.18 -1.48 -0.95 -0.949
EV/Revenue 120.09 47.22 64.16 36.19 36.98 17.27 11.59 9.41 5.96 1.32 1.66 -5.11 -3.85 -3.42 1.61 15.45 15.37 23.19 44.44 224.15 224.153
EV/EBIT -3.06 -2.37 -5.71 -4.90 -6.80 -3.88 -2.73 -2.26 -1.69 -0.34 -0.40 1.09 0.43 0.29 -0.07 -0.63 -0.96 -1.16 -1.46 -0.94 -0.936
EV/FCF -3.27 -3.45 -8.95 -7.24 -9.20 -3.72 -2.39 -1.87 -1.39 -0.29 -0.39 1.04 0.31 0.20 -0.05 -0.51 -1.39 -1.56 -1.66 -0.86 -0.865
Earnings Yield -24.9% -29.3% -15.2% -18.2% -12.6% -17.7% -25.2% -33.0% -42.2% -1.3% -1.8% -1.7% -52.5% -58.6% -50.8% -57.7% -67.7% -69.3% -64.9% -1.2% -1.16%
FCF Yield -24.0% -20.5% -9.8% -12.2% -9.1% -17.7% -27.7% -38.2% -49.1% -1.4% -1.8% -1.9% -1.2% -1.8% -1.4% -1.1% -47.8% -49.8% -54.9% -1.2% -1.18%
PEG Ratio snapshot only 0.000
Shareholder Yield snapshot only 0.14%
Leverage & Solvency
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Current Ratio 4.87 6.35 4.85 3.51 6.24 8.28 6.74 5.13 4.33 4.22 2.36 6.57 6.87 7.37 5.38 4.31 3.95 3.01 3.46 2.25 2.252
Quick Ratio 4.86 6.35 4.85 3.51 6.24 8.28 6.74 5.13 4.33 4.22 2.36 6.57 6.87 7.37 5.38 4.31 3.95 3.01 3.46 2.25 2.252
Debt/Equity 0.33 0.60 0.75 1.02 0.73 0.44 0.51 0.62 0.76 1.07 2.15 0.50 0.50 0.61 0.86 1.78 3.73 4.10 -9.55 -5.41 -5.415
Net Debt/Equity -0.83 -0.99 -0.99 -1.01 -1.19 -1.04 -0.89 -0.76 -0.76 -0.69 -0.63 -1.40 -1.09 -0.94 -1.11 -1.31 -4.65 -3.10 — — —
Debt/Assets 0.17 0.28 0.32 0.35 0.31 0.25 0.28 0.31 0.36 0.44 0.53 0.22 0.26 0.32 0.35 0.44 0.37 0.46 0.57 0.71 0.709
Debt/EBITDA -0.35 -0.61 -0.66 -0.67 -0.84 -0.88 -0.82 -0.76 -0.82 -0.74 -0.65 -0.60 -0.73 -0.76 -0.72 -0.67 -0.39 -0.45 -0.49 -0.66 -0.660
Net Debt/EBITDA 0.87 1.01 0.86 0.66 1.36 2.08 1.45 0.93 0.82 0.48 0.19 1.69 1.58 1.17 0.93 0.49 0.49 0.34 0.15 -0.02 -0.021
Interest Coverage — -287.80 -98.32 -58.46 -65.65 -40.15 -34.15 -30.48 -21.16 -23.90 -26.88 -27.47 -21.90 -20.32 -19.35 -20.32 -31.10 -26.70 -23.73 -17.35 -17.352
Equity Multiplier 1.89 2.11 2.37 2.90 2.35 1.74 1.80 1.96 2.15 2.42 4.07 2.20 1.91 1.92 2.47 4.07 10.09 8.95 -16.80 -7.64 -7.641
Cash Ratio snapshot only 2.053
Debt Service Coverage snapshot only -17.114
Cash to Debt snapshot only 0.968
FCF to Debt snapshot only -1.661
Defensive Interval snapshot only 191.1 days
Efficiency & Turnover
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Asset Turnover 0.02 0.03 0.04 0.07 0.08 0.08 0.10 0.13 0.12 0.12 0.14 0.10 0.05 0.04 0.03 0.02 0.05 0.04 0.03 0.00 0.003
Inventory Turnover 0.00 — — — 0.00 — — — — — — — — — — — — — — — —
Receivables Turnover 0.20 4.78 6633.00 9903.00 1.51 8.24 17.91 11.77 15.73 8.31 11.30 8.68 4.35 3.09 2.08 2.38 11.73 7.91 4.72 0.46 0.464
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 0.30 0.26 0.59 1.04 0.44 0.35 0.25 0.27 0.22 0.20 0.203
DSO 1842 76 0 0 242 44 20 31 23 44 32 42 84 118 175 154 31 46 77 787 787.2 days
DIO — — — — — — — — — 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO — — — — — — — — — 1588 1214 1423 621 352 820 1056 1455 1371 1657 1798 1797.8 days
Cash Conversion Cycle — — — — — — — — — -1544 -1181 -1380 -538 -234 -645 -902 -1424 -1325 -1580 -1011 -1010.6 days
Fixed Asset Turnover snapshot only 0.022
Cash Velocity snapshot only 0.007
Capital Intensity snapshot only 220.194
Growth (YoY)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue -3.3% 83.1% 2.0% 3.2% 6.6% 3.5% 1.9% 1.2% 55.6% 37.5% 29.3% 9.6% -56.7% -68.3% -83.3% -82.6% -2.3% -8.8% -1.5% -90.5% -90.54%
Net Income -21.1% -18.6% -6.1% 0.1% -11.4% -6.3% -16.8% -26.1% -3.0% -18.4% -25.9% -11.7% 39.6% 54.6% 58.9% 38.5% -2.0% -2.3% -1.9% -53.4% -53.44%
EPS 6.9% 8.9% 3.2% 7.4% 20.3% 23.9% 15.1% 8.2% -0.5% -15.3% -24.0% 25.4% 86.3% 89.7% 90.6% 79.3% -1.8% -1.4% -1.1% -9.2% -9.18%
FCF -74.8% 10.9% 27.3% 27.3% 16.7% -52.1% -99.6% -1.2% -66.0% -33.5% -13.9% -7.7% -23.3% -20.8% -17.9% -6.4% 11.5% 20.8% 12.7% 18.7% 18.74%
EBITDA -19.7% -16.0% -2.0% 5.3% -5.5% -0.2% -11.9% -23.0% -0.6% -20.4% -28.2% -24.1% -9.9% 5.0% 14.6% 8.8% -79.5% -59.8% -42.4% 6.2% 6.25%
Op. Income -20.9% -17.5% -3.5% 3.8% -5.9% -10.0% -27.7% -40.9% -20.8% -22.4% -18.3% -21.4% -36.7% -35.5% -26.5% -10.0% 5.2% 11.1% 15.9% 19.1% 19.09%
OCF Growth snapshot only 18.17%
Asset Growth snapshot only -42.49%
Equity Growth snapshot only -1.31%
Debt Growth snapshot only -6.92%
Shares Change snapshot only 40.53%
Growth (CAGR)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue 3Y 84.2% 40.2% 67.2% 91.1% 1.4% 2.6% 2.0% 1.6% 1.3% 1.2% 1.2% 1.1% 72.5% 25.1% -14.1% -25.6% -13.0% -26.4% -40.3% -73.8% -73.77%
Revenue 5Y — — — — — — — — 1.4% 76.3% 77.9% 75.2% 56.0% 83.3% 41.4% 28.7% 37.1% 26.7% 13.3% -30.4% -30.42%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 84.2% 40.2% 67.2% 91.1% 1.4% 2.6% 2.0% 1.6% 1.3% 1.2% 1.2% 1.1% 53.7% 6.6% -41.0% -48.7% -20.2% -33.8% -49.0% — —
Gross Profit 5Y — — — — — — — — 1.4% 75.2% 75.7% 71.8% 45.6% 66.5% 12.8% 3.0% 30.2% 19.0% 3.1% — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 18.0% 27.4% 14.3% 14.6% 39.5% 26.7% 21.2% 19.9% 19.7% 19.8% -6.0% 25.6% 17.7% 8.4% 7.0% 3.5% -7.6% -19.7% -23.0% -25.8% -25.80%
Assets 5Y — — — — — — 30.8% 15.7% 14.9% 14.3% 5.0% 26.3% 25.5% 9.9% 6.6% 4.1% 9.5% 8.8% -6.8% -10.0% -9.99%
Equity 3Y -0.6% 3.0% -11.8% -16.4% 11.5% 12.8% 6.1% 3.8% 2.7% -0.7% -34.8% 11.0% 17.3% 11.7% 5.5% -7.5% -43.1% -53.5% — — —
Book Value 3Y -19.4% -16.5% -27.3% -30.5% -15.9% -10.8% -14.5% -15.7% -16.5% -19.3% -43.4% -14.9% -36.6% -39.6% -42.3% -49.4% -66.3% -74.9% — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue Stability 0.88 0.64 0.69 0.68 0.65 0.77 0.67 0.72 0.74 0.76 0.81 0.85 0.46 0.35 0.20 0.15 0.12 0.02 0.00 0.02 0.024
Earnings Stability 0.98 0.99 0.85 0.90 0.99 0.99 0.88 0.94 0.96 0.99 0.95 0.97 0.07 0.01 0.02 0.17 0.34 0.25 0.18 0.12 0.115
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.97 0.96 0.86 0.82 0.65 0.65 0.84 0.79 0.62 0.00 0.000
Rev. Growth Consistency 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.93 0.98 1.00 0.95 0.97 0.93 0.90 0.99 0.93 0.90 0.95 0.84 0.50 0.50 0.85 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.14 -0.22 -0.61 -0.90 -0.06 0.46 0.24 0.32 -0.08 -0.76 -2.58 0.44 0.56 0.63 1.47 -0.92 -8.63 -8.63 — — —
Gross Margin Trend 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.06 -0.09 -0.29 -0.37 -0.65 -0.63 -0.08 -0.06 -0.01 -2.90 -2.905
FCF Margin Trend -5.92 47.52 32.29 25.96 24.54 16.28 13.44 11.86 16.11 4.67 1.73 0.07 -8.07 -12.58 -25.68 -25.18 -2.81 -4.06 -9.55 -241.66 -241.662
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
OCF/Net Income 0.80 0.52 0.46 0.52 0.68 0.98 1.08 1.15 1.15 1.12 0.99 1.11 2.35 2.98 2.82 1.92 0.70 0.72 0.85 1.02 1.023
FCF/OCF 1.21 1.35 1.40 1.30 1.06 1.02 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.023
CapEx/Revenue 6.4% 3.5% 2.0% 1.2% 22.1% 10.3% 6.4% 4.8% 5.3% 4.6% 3.1% 3.5% 12.2% 17.6% 29.4% 22.2% 2.7% 0.5% 0.9% 9.8% 9.84%
CapEx/Depreciation snapshot only 0.030
Accruals Ratio -0.12 -0.29 -0.27 -0.26 -0.15 -0.01 0.04 0.08 0.07 0.06 -0.01 0.05 0.33 0.48 0.53 0.27 -0.22 -0.24 -0.14 0.02 0.019
Sloan Accruals snapshot only -0.514
Cash Flow Adequacy snapshot only -2632.079
Dividends & Buybacks
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Dividend Yield 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.04 $0.04 $0.04 $0.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak 0 0 0 0 — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.4% 0.5% 0.4% 0.1% 0.2% 0.2% 0.2% 0.0% 0.0% 0.0% 0.1% 0.14%
Net Buyback Yield -20.2% -28.1% -2.6% -3.1% -15.4% -35.0% -46.9% -57.1% -34.2% 0.3% 0.5% -2.1% -1.2% -1.6% -1.4% -7.1% -18.9% -20.8% -21.4% -51.0% -51.03%
Total Shareholder Return -20.1% -28.0% -2.6% -3.1% -15.4% -35.0% -46.9% -57.1% -34.2% 0.3% 0.5% -2.1% -1.2% -1.6% -1.4% -7.1% -18.9% -20.8% -21.4% -51.0% -51.03%
DuPont Factors
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.99 0.91 0.55 0.47 0.47 0.61 0.95 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.97 0.98 0.99 1.01 1.02 1.04 1.04 1.04 1.05 1.04 1.04 1.04 1.05 1.05 1.05 1.05 1.03 1.04 1.04 1.06 1.058
EBIT Margin -39.22 -19.96 -11.24 -7.39 -5.44 -4.46 -4.25 -4.16 -3.52 -3.88 -4.18 -4.68 -8.90 -11.62 -21.47 -24.51 -16.05 -19.95 -30.43 -239.60 -239.598
Asset Turnover 0.02 0.03 0.04 0.07 0.08 0.08 0.10 0.13 0.12 0.12 0.14 0.10 0.05 0.04 0.03 0.02 0.05 0.04 0.03 0.00 0.003
Equity Multiplier 1.63 1.78 1.72 1.97 2.14 1.86 1.98 2.25 2.25 1.94 2.24 2.09 2.01 2.11 2.95 2.61 2.86 2.79 4.30 9.25 9.245
Per Share
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
EPS (Diluted TTM) $-17.17 $-17.35 $-16.18 $-16.08 $-13.69 $-13.20 $-13.73 $-14.76 $-13.76 $-15.22 $-17.03 $-11.01 $-1.88 $-1.57 $-1.60 $-2.28 $-5.27 $-3.71 $-3.35 $-2.49 $-2.49
Book Value/Share $18.03 $17.43 $13.66 $10.03 $14.75 $24.42 $20.68 $16.85 $13.54 $9.95 $4.86 $13.72 $4.60 $3.83 $2.62 $1.30 $0.56 $0.39 $-0.16 $-0.28 $0.59
Tangible Book/Share $18.03 $17.43 $13.66 $10.03 $14.75 $24.42 $20.68 $16.85 $13.54 $9.95 $4.86 $13.72 $4.60 $3.83 $2.62 $1.30 $0.56 $0.39 $-0.16 $-0.28 $-0.28
Revenue/Share $0.45 $0.89 $1.45 $2.16 $2.46 $2.86 $3.10 $3.40 $3.73 $3.83 $3.95 $2.49 $0.37 $0.27 $0.15 $0.15 $0.34 $0.18 $0.11 $0.01 $0.35
FCF/Share $-16.59 $-12.19 $-10.40 $-10.81 $-9.89 $-13.26 $-15.09 $-17.09 $-16.02 $-17.23 $-16.93 $-12.29 $-4.48 $-4.72 $-4.56 $-4.40 $-3.72 $-2.67 $-2.83 $-2.54 $-3.88
OCF/Share $-13.72 $-9.03 $-7.44 $-8.31 $-9.35 $-12.97 $-14.89 $-16.92 $-15.82 $-17.06 $-16.81 $-12.21 $-4.43 $-4.67 $-4.52 $-4.37 $-3.71 $-2.67 $-2.83 $-2.54 $-3.87
Cash/Share $20.81 $27.75 $23.78 $20.34 $28.35 $36.19 $28.96 $23.13 $20.72 $17.48 $13.52 $25.96 $7.29 $5.96 $5.16 $4.01 $4.72 $2.78 $2.01 $1.48 $4.93
EBITDA/Share $-17.08 $-17.09 $-15.64 $-15.28 $-12.89 $-12.25 $-12.72 $-13.67 $-12.65 $-14.36 $-16.06 $-11.33 $-3.15 $-3.09 $-3.14 $-3.48 $-5.32 $-3.52 $-3.18 $-2.32 $-2.32
Debt/Share $5.90 $10.45 $10.30 $10.22 $10.79 $10.75 $10.45 $10.40 $10.36 $10.62 $10.44 $6.79 $2.29 $2.34 $2.25 $2.31 $2.10 $1.58 $1.54 $1.53 $1.53
Net Debt/Share $-14.91 $-17.30 $-13.48 $-10.13 $-17.56 $-25.44 $-18.50 $-12.73 $-10.36 $-6.87 $-3.07 $-19.17 $-5.00 $-3.61 $-2.91 $-1.70 $-2.62 $-1.20 $-0.47 $0.05 $0.05
Academic Models
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -15.013
Altman Z-Prime snapshot only -32.651
Piotroski F-Score 1 4 2 2 4 5 4 4 1 1 2 3 3 3 3 2 2 2 2 0 0
Beneish M-Score -3.04 0.32 1.66 1.63 5.39 -1.67 -1.00 -0.24 -0.53 -1.23 -2.75 -3.17 — -1.05 -0.49 -0.80 — — — — —
Ohlson O-Score snapshot only 0.810
Net-Net WC snapshot only $-0.82
Credit
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Credit Rating snapshot only B-
Credit Score 41.57 29.76 28.47 26.72 33.32 33.89 27.32 27.47 27.54 26.74 23.05 31.29 31.86 29.66 29.72 27.10 23.80 24.06 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only -7.096
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 16
Sector Credit Rank snapshot only 15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms